These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9290733)

  • 1. Graft arteriosclerosis: molecular features of macrophage activation.
    Russell ME
    Transplant Proc; 1997 Sep; 29(6):2542-3. PubMed ID: 9290733
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte adhesion and cellular immune reactions in chronic rejection and graft arteriosclerosis.
    Hansson GK; Geng YJ; Holm J; Stemme S
    Transplant Proc; 1993 Apr; 25(2):2050-1. PubMed ID: 8470268
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophages and transplant arteriosclerosis: known and novel molecules.
    Russell ME
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S111-5. PubMed ID: 8719472
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts.
    Yi S; Hawthorne WJ; Lehnert AM; Ha H; Wong JK; van Rooijen N; Davey K; Patel AT; Walters SN; Chandra A; O'Connell PJ
    J Immunol; 2003 Mar; 170(5):2750-8. PubMed ID: 12594306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bidirectional interactions between T cells and the extracellular matrix.
    Postlethwaite AE
    Transpl Immunol; 1997 Dec; 5(4):289-91. PubMed ID: 9504149
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective rejection of porcine islet xenografts by macrophages.
    Fu Y; Lu X; Yi S; Wu J; O'Hara JM; Hawthorne WJ; Hucker K; O'Connell PJ
    Xenotransplantation; 2008; 15(5):307-12. PubMed ID: 19134160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic allograft arteriosclerosis: contributing factors and molecular mechanisms in the light of experimental studies.
    Räisänen-Sokolowski A; Häyry P
    Transpl Immunol; 1996 Jun; 4(2):91-8. PubMed ID: 8843584
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody and complement in graft rejection.
    Sanfilippo F; Baldwin WM
    Transplant Proc; 1997; 29(1-2):179-80. PubMed ID: 9122952
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants.
    Ratliff NB; McMahon JT
    J Heart Lung Transplant; 1995; 14(2):338-45. PubMed ID: 7779854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of macrophages in allograft rejection.
    Wyburn KR; Jose MD; Wu H; Atkins RC; Chadban SJ
    Transplantation; 2005 Dec; 80(12):1641-7. PubMed ID: 16378052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout models of chronic cardiac rejection and graft arteriosclerosis: intimal thickening develops independent of Th1 and Th2 cytokines.
    Russell ME; Räisänen-Sokolowski A; Mottram P; Glysing-Jensen T
    Transplant Proc; 1997 Sep; 29(6):2531-2. PubMed ID: 9290728
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. 4th Alexis Carrel Conference. Proceedings. Riksgränsen-Kiruna, Sweden, June 13-17, 1992.
    Transplant Proc; 1993 Apr; 25(2):2019-105. PubMed ID: 8097066
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
    Russell ME; Hancock WW; Akalin E; Wallace AF; Glysing-Jensen T; Willett TA; Sayegh MH
    J Clin Invest; 1996 Feb; 97(3):833-8. PubMed ID: 8609241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin contamination of reagents used during isolation and purification of human pancreatic islets.
    Linetsky E; Inverardi L; Kenyon NS; Alejandro R; Ricordi C
    Transplant Proc; 1998 Mar; 30(2):345-6. PubMed ID: 9532069
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of macrophages in xenograft rejection.
    Cadili A; Kneteman N
    Transplant Proc; 2008 Dec; 40(10):3289-93. PubMed ID: 19100374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROCK inhibition impedes macrophage polarity and functions.
    Liu Y; Tejpal N; You J; Li XC; Ghobrial RM; Kloc M
    Cell Immunol; 2016 Feb; 300():54-62. PubMed ID: 26711331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of allograft arteriosclerosis after retransplantation to donor strain.
    Mennander A; Häyry P
    Transplantation; 1996 Aug; 62(4):526-9. PubMed ID: 8781620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic science aspects of chronic rejection: induction of protective genes to prevent development of transplant arteriosclerosis.
    Hancock WW
    Transplant Proc; 1998 Jun; 30(4):1585-9. PubMed ID: 9636639
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity.
    Ochando J; Conde P
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.